Treatment of Breast Cancer with Natural Products

Dr. Yachana Mishra, PhD, is an Associate Professor at the School of Bioengineering and Biosciences, Lovely Professional University, Phagwara (Punjab), India. She received her Ph.D. degree from Indian Grassland and Fodder Research Institute (IGFRI), Bundelkhand University, Jhansi (U.P.), India. Dr. Mishra has published more than 55 research and review articles in journals of high repute, 25 book chapters, 7 books, 4 Indian patents (Filed) and 5 Indian Copyrights (Granted). She has 15+ years of academic and research experience. She is a life member of different reputed organizations like Indian Science Congress Association, Kolkata (India), and the Society of Pharmaceutical Education and Research (SPER), India. She also serves as a reviewer of various journals of high repute. Her research areas include nanomedicine, cancer, diabetes, phytopharmaceuticals, and nanocarriers.Dr. Vijay Mishra, PhD, is a Professor at the School of Pharmaceutical Sciences, Lovely Professional University, Phagwara (Punjab), India. He earned his doctoral degree in Pharmaceutical Sciences from Dr. H.S. Gour Central University, Sagar (MP), India. He has 15+ years of academic and research experience. Dr. Mishra has authored more than 160 research and review articles in various peer-reviewed international journals of high repute, 25 book chapters, 9 books, 10 Indian patents (filed and published), 1 Australian and 1 Indian patent (granted) and 5 Indian Copyrights (Granted). He has an h-index 43 and 6400+ citations to his credit. He has been a recipient of several internationally acclaimed fellowships and awards including Graduate Research Fellowship (AICTE, New Delhi), UGC-BSR Senior Research Fellowship (UGC, New Delhi) and International Travel Award/Grant (DBT, New Delhi). He is a life member of Indian Science Congress Association, Kolkata, India. He serves as an Editorial Board Member of various peer-reviewed journals. Dr. Mishra has been selected as the World's Top 2% scientists in 2021, 2022, 2023, and 2024 as per Stanford University, USA report. His current research interests encompass nanomedicine, cancer, phytotherapeutics, dendrimers, carbon nanotubes, and novel drug delivery systems.